Targeted Metabolomics Identifies Pharmacodynamic Biomarkers for BIO 300 Mitigation of Radiation-Induced Lung Injury.

Jones JW, Jackson IL, Vujaskovic Z, Kaytor MD, Kane MA

Open source

DOI
10.1007/s11095-017-2200-9
Published
2017 Dec
Container
Pharmaceutical research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11095-017-2200-9,
  title = {Targeted Metabolomics Identifies Pharmacodynamic Biomarkers for BIO 300 Mitigation of Radiation-Induced Lung Injury.},
  author = {Jones JW and Jackson IL and Vujaskovic Z and Kaytor MD and Kane MA},
  year = {2017},
  journal = {Pharmaceutical research},
  doi = {10.1007/s11095-017-2200-9},
  url = {https://doi.org/10.1007/s11095-017-2200-9}
}

RIS

TY  - JOUR
TI  - Targeted Metabolomics Identifies Pharmacodynamic Biomarkers for BIO 300 Mitigation of Radiation-Induced Lung Injury.
AU  - Jones JW
AU  - Jackson IL
AU  - Vujaskovic Z
AU  - Kaytor MD
AU  - Kane MA
PY  - 2017
JO  - Pharmaceutical research
DO  - 10.1007/s11095-017-2200-9
UR  - https://doi.org/10.1007/s11095-017-2200-9
ER  - 

APA

JW, J., IL, J., Z, V., MD, K., & MA, K. (2017). Targeted Metabolomics Identifies Pharmacodynamic Biomarkers for BIO 300 Mitigation of Radiation-Induced Lung Injury.. Pharmaceutical research. https://doi.org/10.1007/s11095-017-2200-9

Source records